EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSVVUG00000026231
Gene Symbol: ATP1B3
3 Cross references
299 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSVVUG00000024124
Gene Symbol: ATR
3 Cross references
206 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSVVUG00000005397
Gene Symbol: AXL
3 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSVVUG00000001562
Gene Symbol: BRAF
3 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSVVUG00000017738
Gene Symbol: BCL2
3 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSVVUG00000008397
Gene Symbol: BCL2L1
3 Cross references
286 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSVVUG00000019242
Gene Symbol: BCR
3 Cross references
274 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSVVUG00000004990
Gene Symbol: BTK
3 Cross references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSVVUG00000006006
Gene Symbol: CCR1
4 Cross references
299 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSVVUG00000006001
Gene Symbol: CCR2
4 Cross references
286 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSVVUG00000022087
Gene Symbol: CCR4
3 Cross references
254 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSVVUG00000005998
Gene Symbol: CCR5
3 Cross references
298 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).